MAQUET Medical Systems USA Receives 510(k) Clearance for VOLISTA™ Surgical Lighting System

  MAQUET Medical Systems USA Receives 510(k) Clearance for VOLISTA™ Surgical
  Lighting System

 New offering complements MAQUET’s portfolio of innovative hospital lighting
                  and will be available for sale in the U.S.

Business Wire

WAYNE, N.J. -- October 10, 2013

MAQUET Medical Systems USA, a leading supplier of medical equipment for
operating, hybrid and induction rooms, intensive care units and patient
transport, today announced the U.S. Food and Drug Administration (FDA) granted
510(k) clearance for the VOLISTA Surgical Lighting System. VOLISTA, an
extension of the TRIOP™ light assembly, is the first lighting system that
allows surgeons the flexibility to easily configure the equipment to meet the
needs of the procedure, instead of working within the confines of a static
operating room.

“The VOLISTA system is another addition to our portfolio of hospital lighting
that enables surgeons to configure the operating room in the way they find
most useful and productive, based on the procedure that they are conducting,”
said Raoul Quintero, President of MAQUET Medical Systems USA. “Furthermore,
the VOLISTA system allows operating rooms to become more versatile and used
for a wide variety of procedures, ultimately helping to ensure that each
operating room in the hospital is being maximized.”

VOLISTA surgical lighting system incorporates MAQUET’s innovative Luminance
Management Device (LMD) technology, providing surgeons a clear and accurate
view of anatomical structures during surgery, minimal peripheral reflections
and assurance of equivalent light levels. The VOLISTA system also offers the
choice of three color temperatures (3900, 4500 or 5100°K) to adapt the
illumination based on the surgery being performed.

About MAQUET

MAQUET, a trusted partner for hospitals and physicians for over 175 years, is
the global leader in providing medical systems that meet the needs of the most
medically challenging patients, while exceeding the expectations of the
hospital teams that care for them. MAQUET designs, develops and distributes
innovative therapy solutions and infrastructure capabilities for high-acuity
areas within the hospital including the operating room (OR), hybrid OR/cath
lab and intensive care unit (ICU) as well as intra and inter hospital patient
transport.

Headquartered in Rastatt, Germany, MAQUET is the largest subsidiary of the
publicly listed Getinge Group AB of Sweden. MAQUET generated about 1.5 billion
Euros in 2012, representing more than half of the Getinge Group’s annual
revenue of 2.7 billion Euros. MAQUET has 6,300 employees in 45 international
sales and service organizations, as well as a network of more than 300 sales
representatives. For more information please visit www.maquet.com.

MAQUET – The Gold Standard
www.maquet.com
www.getinge.com

Contact:

W2O Group
Susan Neath, 212-301-7182
sneath@w2ogroup.com